Clinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Study
- Sundar Jagannath
- , Thierry Facon
- , Ashraf Z. Badros
- , Moshe Levy
- , Phillipe Moreau
- , Sosana Delimpasi
- , Maryana Simonova
- , Ivan Spicka
- , Iryrna Kriachok
- , Maria Gavriatopoulou
- , Halyna Pylypenko
- , Holger W. Auner
- , Xavier Leleu
- , Vadim Doronin
- , Ganna Usenko
- , Roman Hajek
- , Reuben Benjamin
- , Tuphan Kanti Dolai
- , Dinesh Kumar Sinha
- , Chris P. Venner
Research output: Contribution to journal › Meeting Abstract › peer-review